Eris M. J. Biopharm Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.37 Cr
as on 16-11-2024
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.71 Cr
as on 16-11-2024
- Revenue 843.69%
(FY 2023)
- Profit -1258.00%
(FY 2023)
- Ebitda -866.38%
(FY 2023)
- Net Worth 6202.23%
(FY 2023)
- Total Assets 288.73%
(FY 2023)
About Eris M. J. Biopharm
The Corporate was formerly known as Kinedex Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.37 Cr.
The company has closed loans amounting to ₹3.71 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amol Shah, Kaushal Shah, Amit Bakshi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51397GJ2002PTC112851
- Company No.
017820
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eris M. J. Biopharm Private Limited offer?
Eris M. J. Biopharm Private Limited offers a wide range of products and services, including Popular Category, Bone & Joint Care, Health Conditions, Stomach Care, Bone, Joint & Muscle Care, Pain Relief.
Who are the key members and board of directors at Eris M. J. Biopharm?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Shah  | Director | 12-Jan-2022 | Current |
| Kaushal Shah | Director | 12-Dec-2016 | Current |
| Amit Bakshi | Director | 23-Nov-2016 | Current |
| Akshay Shah | Director | 12-Jan-2022 | Current |
| Krishnakumar Vaidyanathan | Director | 17-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Eris M. J. Biopharm.
Eris M. J. Biopharm Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 843.69% increase. The company also saw a substantial fall in profitability, with a 1258% decrease in profit. The company's net worth Soared by an impressive increase of 6202.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eris M. J. Biopharm?
In 2023, Eris M. J. Biopharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fine Aromatics And Herbal Extracts Private LimitedActive 20 years 2 monthsAmol Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Jul 2016 | ₹2.59 M | Satisfied |
Others Creation Date: 05 Feb 2016 | ₹4.50 M | Satisfied |
Ing Vysya Bank Limited Creation Date: 21 Mar 2013 | ₹1.75 Cr | Satisfied |
How Many Employees Work at Eris M. J. Biopharm?
Eris M. J. Biopharm has a workforce of 202 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eris M. J. Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris M. J. Biopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
